This inventor holds 1 USPTO granted patent. Top assignee: Naturon Limited. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Hong Xue
Introduction
Hong Xue is a notable inventor based in Hong Kong, CN. He has made significant strides in the field of anxiety treatment through his innovative research and development. With a focus on natural compounds, his work aims to provide effective solutions for patients suffering from anxiety without the sedative side effects commonly associated with traditional treatments.
Latest Patents
Hong Xue holds a patent for a compound aimed at the treatment of anxiety. The patent, titled "Compound for treatment of anxiety and methods of preparation and use thereof," describes a method for preventing or treating anxiety in patients. This method involves administering wogonin to patients in an effective dose that does not cause sedative or myorelaxant side effects. Additionally, the patent outlines methods for extracting wogonin from the roots of Georgi, showcasing his commitment to developing natural remedies.
Career Highlights
Hong Xue is currently associated with Naturon Limited, where he continues to explore innovative solutions in the field of mental health. His work is characterized by a dedication to improving patient outcomes through research and development of natural compounds.
Collaborations
Hong Xue collaborates with talented individuals in his field, including Hui Kwok Min and Hongyan Wang, who contribute to his research efforts. Their combined expertise enhances the potential for groundbreaking advancements in anxiety treatment.
Conclusion
In summary, Hong Xue's contributions to the field of anxiety treatment through his innovative patent and collaboration with skilled professionals highlight his commitment to improving mental health solutions. His work exemplifies the potential of natural compounds in addressing complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile